# KEMPER Corp: financial statements, quarterly

KMPR · NYSE · CIK 860748 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kmpr.md) · [Financials](/companies/kmpr/financials.md) · [Filings](/companies/kmpr/filings.md) · [Insiders](/companies/kmpr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kmpr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,199](/filings/0000860748-24-000227.md) | [1,187 d](/filings/0000860748-26-000014.md) | [1,143](/filings/0000860748-25-000131.md) | [1,130](/filings/0000860748-25-000184.md) | [1,179](/filings/0000860748-25-000214.md) | [1,187 d](/filings/0000860748-26-000014.md) | [1,193](/filings/0000860748-26-000045.md) | [1,226](/filings/0000860748-26-000084.md) | [1,240](/filings/0000860748-25-000214.md) | [1,131 d](/filings/0000860748-26-000014.md) | [1,107](/filings/0000860748-26-000045.md) | [1,093](/filings/0000860748-26-000084.md) |
| Operating income | $m | [(38.9)](/filings/0000860748-24-000227.md) | [63.0 d](/filings/0000860748-24-000046.md) | [86.3](/filings/0000860748-24-000132.md) | [114](/filings/0000860748-24-000200.md) | [132](/filings/0000860748-24-000227.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [14.1](/filings/0000860748-24-000227.md) | [13.9 d](/filings/0000860748-26-000014.md) | [14.0](/filings/0000860748-25-000131.md) | [13.9](/filings/0000860748-25-000184.md) | [14.4](/filings/0000860748-25-000214.md) | [14.6 d](/filings/0000860748-26-000014.md) | [11.4](/filings/0000860748-25-000131.md) | [9.0](/filings/0000860748-25-000184.md) | [9.1](/filings/0000860748-25-000214.md) | [9.0 d](/filings/0000860748-26-000014.md) | not reported | not reported |
| Income tax | $m | [(44.4)](/filings/0000860748-24-000227.md) | [12.2 d](/filings/0000860748-26-000014.md) | [16.4](/filings/0000860748-25-000131.md) | [17.5](/filings/0000860748-25-000184.md) | [18.5](/filings/0000860748-25-000214.md) | [23.6 d](/filings/0000860748-26-000014.md) | [22.8](/filings/0000860748-26-000045.md) | [17.7](/filings/0000860748-26-000084.md) | [(8.9)](/filings/0000860748-25-000214.md) | [(3.5) d](/filings/0000860748-26-000014.md) | [(3.5)](/filings/0000860748-26-000045.md) | [(1.0)](/filings/0000860748-26-000084.md) |
| Net income | $m | [(146)](/filings/0000860748-24-000227.md) | [51.4 d](/filings/0000860748-26-000014.md) | [71.3](/filings/0000860748-25-000131.md) | [75.4](/filings/0000860748-25-000184.md) | [73.7](/filings/0000860748-25-000214.md) | [97.4 d](/filings/0000860748-26-000014.md) | [99.7](/filings/0000860748-26-000045.md) | [72.6](/filings/0000860748-26-000084.md) | [(21.0)](/filings/0000860748-25-000214.md) | [(8.0) d](/filings/0000860748-26-000014.md) | [(1.7)](/filings/0000860748-26-000045.md) | [(465)](/filings/0000860748-26-000084.md) |
| Diluted EPS | $ per share | [(2.28)](/filings/0000860748-24-000227.md) | not reported | [1.10](/filings/0000860748-25-000131.md) | [1.16](/filings/0000860748-25-000184.md) | [1.14](/filings/0000860748-25-000214.md) | not reported | [1.54](/filings/0000860748-26-000045.md) | [1.12](/filings/0000860748-26-000084.md) | [(0.34)](/filings/0000860748-25-000214.md) | not reported | [(0.03)](/filings/0000860748-26-000045.md) | [(7.90)](/filings/0000860748-26-000084.md) |
| Basic EPS | $ per share | [(2.28)](/filings/0000860748-24-000227.md) | not reported | [1.11](/filings/0000860748-25-000131.md) | [1.17](/filings/0000860748-25-000184.md) | [1.15](/filings/0000860748-25-000214.md) | not reported | [1.56](/filings/0000860748-26-000045.md) | [1.13](/filings/0000860748-26-000084.md) | [(0.34)](/filings/0000860748-25-000214.md) | not reported | [(0.03)](/filings/0000860748-26-000045.md) | [(7.90)](/filings/0000860748-26-000084.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000860748-23-000185.md) | [0.1](/filings/0000860748-25-000053.md) | not reported | not reported | not reported | [0.1](/filings/0000860748-26-000014.md) | not reported | not reported | not reported | [0.1](/filings/0000860748-26-000014.md) | not reported | not reported |
| Total assets | $bn | [12.5](/filings/0000860748-23-000185.md) | [12.7](/filings/0000860748-26-000014.md) | [12.6](/filings/0000860748-25-000131.md) | [12.6](/filings/0000860748-25-000184.md) | [12.6](/filings/0000860748-25-000214.md) | [12.6](/filings/0000860748-26-000014.md) | [12.5](/filings/0000860748-26-000045.md) | [12.5](/filings/0000860748-26-000084.md) | [12.4](/filings/0000860748-25-000214.md) | [12.5](/filings/0000860748-26-000084.md) | [12.4](/filings/0000860748-26-000045.md) | [11.9](/filings/0000860748-26-000084.md) |
| Total liabilities | $bn | [10.2](/filings/0000860748-23-000185.md) | [10.2](/filings/0000860748-25-000053.md) | [10.0](/filings/0000860748-24-000132.md) | [9.9](/filings/0000860748-24-000200.md) | [10.1](/filings/0000860748-24-000227.md) | [9.8](/filings/0000860748-26-000014.md) | [9.6](/filings/0000860748-25-000131.md) | [9.7](/filings/0000860748-25-000184.md) | [9.7](/filings/0000860748-25-000214.md) | [9.8](/filings/0000860748-26-000084.md) | [9.8](/filings/0000860748-26-000045.md) | [9.7](/filings/0000860748-26-000084.md) |
| Long-term debt | $bn | [1.4](/filings/0000860748-23-000185.md) | [1.4](/filings/0000860748-25-000053.md) | [1.4](/filings/0000860748-24-000132.md) | [1.4](/filings/0000860748-24-000200.md) | [1.4](/filings/0000860748-24-000227.md) | [0.9](/filings/0000860748-26-000014.md) | [0.9](/filings/0000860748-25-000131.md) | [0.9](/filings/0000860748-25-000184.md) | [0.9](/filings/0000860748-25-000214.md) | [0.9](/filings/0000860748-26-000084.md) | [0.9](/filings/0000860748-26-000045.md) | [0.9](/filings/0000860748-26-000084.md) |
| Current portion of debt | $bn | not reported | [0.0](/filings/0000860748-25-000053.md) | not reported | not reported | not reported | [0.4](/filings/0000860748-26-000014.md) | not reported | not reported | not reported | [0.0](/filings/0000860748-26-000014.md) | not reported | not reported |
| Shareholders' equity | $bn | [2.4](/filings/0000860748-23-000185.md) | [2.5](/filings/0000860748-25-000053.md) | [2.6](/filings/0000860748-24-000132.md) | [0.4](/filings/0000860748-24-000227.md) | [2.8](/filings/0000860748-24-000227.md) | [2.8](/filings/0000860748-26-000014.md) | [0.4](/filings/0000860748-25-000184.md) | [0.4](/filings/0000860748-25-000214.md) | [2.7](/filings/0000860748-25-000214.md) | [2.7](/filings/0000860748-26-000084.md) | [2.6](/filings/0000860748-26-000045.md) | [2.2](/filings/0000860748-26-000084.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(38.6) d](/filings/0000860748-24-000227.md) | [(29.7) d](/filings/0000860748-26-000014.md) | [43.0](/filings/0000860748-25-000131.md) | [22.9 d](/filings/0000860748-25-000184.md) | [142 d](/filings/0000860748-25-000214.md) | [175 d](/filings/0000860748-26-000014.md) | [180](/filings/0000860748-26-000045.md) | [89.6 d](/filings/0000860748-26-000084.md) | [140 d](/filings/0000860748-25-000214.md) | [175 d](/filings/0000860748-26-000014.md) | [88.8](/filings/0000860748-26-000045.md) | [30.5 d](/filings/0000860748-26-000084.md) |
| Capital expenditure | $m | [13.7 d](/filings/0000860748-24-000227.md) | [14.7 d](/filings/0000860748-26-000014.md) | [15.3](/filings/0000860748-25-000131.md) | [17.7 d](/filings/0000860748-25-000184.md) | [10.5 d](/filings/0000860748-25-000214.md) | [9.7 d](/filings/0000860748-26-000014.md) | [7.7](/filings/0000860748-26-000045.md) | [7.6 d](/filings/0000860748-26-000084.md) | [6.5 d](/filings/0000860748-25-000214.md) | [8.8 d](/filings/0000860748-26-000014.md) | [10.9](/filings/0000860748-26-000045.md) | [11.4 d](/filings/0000860748-26-000084.md) |
| Dividends paid | $m | [20.2 d](/filings/0000860748-24-000227.md) | [20.3 d](/filings/0000860748-26-000014.md) | [19.5](/filings/0000860748-25-000131.md) | [20.3 d](/filings/0000860748-25-000184.md) | [20.3 d](/filings/0000860748-25-000214.md) | [20.0 d](/filings/0000860748-26-000014.md) | [20.2](/filings/0000860748-26-000045.md) | [20.8 d](/filings/0000860748-26-000084.md) | [19.7 d](/filings/0000860748-25-000214.md) | [18.9 d](/filings/0000860748-26-000014.md) | [18.3](/filings/0000860748-26-000045.md) | [19.3 d](/filings/0000860748-26-000084.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0000860748-26-000014.md) | [0.0](/filings/0000860748-25-000131.md) | [0.0 d](/filings/0000860748-25-000184.md) | [25.0 d](/filings/0000860748-25-000214.md) | [13.9 d](/filings/0000860748-26-000014.md) | [4.0](/filings/0000860748-26-000045.md) | [28.5 d](/filings/0000860748-26-000084.md) | [219 d](/filings/0000860748-25-000214.md) | [50.6 d](/filings/0000860748-26-000014.md) | [0.0](/filings/0000860748-26-000045.md) | [0.0 d](/filings/0000860748-26-000084.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.9](/filings/0000860748-23-000185.md) | [63.9](/filings/0000860748-24-000132.md) | [64.0](/filings/0000860748-24-000200.md) | [64.1](/filings/0000860748-24-000227.md) | [64.8](/filings/0000860748-25-000131.md) | [64.9](/filings/0000860748-25-000184.md) | [64.9](/filings/0000860748-25-000214.md) | [64.7](/filings/0000860748-26-000045.md) | [64.6](/filings/0000860748-26-000084.md) | [61.5](/filings/0000860748-25-000214.md) | [58.7](/filings/0000860748-26-000045.md) | [58.9](/filings/0000860748-26-000084.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,923,154 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000860748-26-000084.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.